Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2024-05-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
第二届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details the convening and decisions of the second Supervisory Board's ninth meeting, including approval of a restricted stock grant plan. The document is short (911 characters) and primarily announces the meeting resolution and voting results. It does not contain financial statements, detailed financial data, or comprehensive report content. It is not a full report but an announcement of a board meeting decision. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2024-05-09 Chinese
关于向激励对象首次授予限制性股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial grant of restricted stock under a 2024 stock incentive plan approved at the 2023 annual general meeting. It details the approval process, grant conditions, allocation, vesting schedule, performance criteria, and legal and financial advisor opinions. The document is a formal announcement of a capital incentive event involving share grants to employees and executives, including board members. It is not a full financial report, audit report, or earnings release. It is not a proxy statement or voting result announcement. It is a specific announcement about a share-based compensation plan and the initial grant of restricted shares, which falls under capital structure changes and financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (8396 characters) and detailed content confirm it is not a brief report publication announcement or a regulatory filing. Confidence is high due to the detailed nature and specificity of the announcement.
2024-05-09 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2023年年度股东大会决议公告" which translates to "2023 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2023 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the annual report, board work report, financial report, profit distribution, and other corporate matters. The document includes attendance details, voting methods, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements but rather the official announcement of the AGM resolutions and voting outcomes. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 6000 characters, indicating it is not a brief notice but a detailed voting result announcement. Confidence is high due to clear AGM resolution and voting result content.
2024-05-09 Chinese
广东信达律师事务所关于公司2024年限制性股票激励计划首次授予事项的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by Guangdong Xinda Law Firm regarding the first grant of a 2024 restricted stock incentive plan by Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details the legal compliance, approvals, and authorizations related to the stock incentive plan. The document is a standalone legal opinion on a specific capital incentive event, not a full annual or interim financial report, nor an announcement of voting results or management changes. It is not a regulatory filing or a report publication announcement since it contains substantive legal analysis and conclusions. The content focuses on the legal aspects of a capital/financing event (stock incentive plan grant). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4510 characters, which is substantive and not a brief announcement or certification.
2024-05-09 Chinese
广东信达律师事务所关于深圳市美好创亿医疗科技股份有限公司2023年年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It details the convening and holding of the AGM, the qualifications of attendees, the voting procedures, and the voting results. The document includes a summary table of voting results on various proposals related to the annual report, board reports, financial statements, profit distribution, and other AGM agenda items. The document is not the annual report itself but a legal opinion on the AGM process and results. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including legal opinions and voting results.
2024-05-09 Chinese
监事会关于2024年限制性股票激励计划首次授予激励对象名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from the Supervisory Board regarding the initial grant list of incentive recipients under a 2024 restricted stock incentive plan. It references compliance with company law, securities law, stock exchange listing rules, and internal governance documents. The content focuses on the eligibility and qualifications of incentive recipients rather than financial results, management changes, or shareholder votes. It is not a full report, earnings release, or regulatory filing about financial performance. It is also not an announcement of voting results or a proxy solicitation. The document is a formal opinion related to a stock incentive plan, which aligns best with a Regulatory Filing (RNS) as it does not fit other more specific categories and is a compliance-related statement.
2024-05-09 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.